BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment

Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...

April 22, 2024 | News

Eisai Launches Injectable Fycompa in Japan for Epilepsy Treatment

Eisai Co., Ltd. announcedthat the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (I...

April 19, 2024 | News

Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis

Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant World Hepatitis Allianc...

April 16, 2024 | News

Serum Institute of India and Univercells Unite to Make Personalized Cancer Treatments Widely Available

Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator,...

April 12, 2024 | News

Rising Prevalence of Inflammatory Bowel Disease in Developing Countries Signals Urgent Need for Innovative Treatments

IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions like China....

April 11, 2024 | News

Transcenta and Agilent Collaborate on Companion Diagnostic for Advanced Gastric Cancer Trial

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

April 09, 2024 | News

Ractigen Therapeutics Launches Pioneering Phase I Clinical Trial for Bladder Cancer with First Patient Dosed in Collaboration with GenesisCare

Ractigen Therapeutics, a pioneer in small activating RNA (saRNA) therapeutics, achieved a major milestone with the first patient dosed in its First-in-huma...

April 04, 2024 | News

Invenra and Catalent Forge Partnership to Advance Cancer Treatment Innovations

Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...

April 03, 2024 | News

Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers

Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...

April 02, 2024 | News

GE HealthCare Completes Acquisition of MIM Software, Enhancing Precision Care Portfolio

With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated sol...

April 02, 2024 | News

Integra LifeSciences Completes Acquisition of Acclarent, Expands Market Reach in ENT Surgical Solutions

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, announced it has successfully completed it...

April 02, 2024 | News

Eisai and Biogen Seek FDA Approval for Monthly Alzheimer's Treatment Dosing

Eisai Co., Ltd. and Biogen Inc. have taken a significant step forward in the fight against Alzheimer’s disease by submitting a Supplemental Biologics...

April 01, 2024 | News

Bridge Biotherapeutics Partners with Emory University to Advance Lung Cancer Treatment

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announ...

April 01, 2024 | News

Baird Medical Devices, Inc. Introduces Next-Generation Ceramic Thyroid Ablation Needle

Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China&nb...

April 01, 2024 | News

Stay Connected